Researchers say work lays the foundation for a first-line, deployable antiviral platform that is virus agnostic and modular.

For a few dozen people in the world, the downside of living with a rare immune condition comes with a surprising ...

President Donald Trump's administrations have been notorious for an array of "alternative facts" — ranging from the ...